Simultaneously, the plasma adiponectin levels in ALS patients were shown to be lower than those in the control group (46.26 ± 12.85 vs. 63.05 ± 13.60, P = 0.002). The gene discussed is ADIPOQ; the disease is amyotrophic lateral sclerosis.